OABIW — OmniAb, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1846253 ·
Last close
$0.09
Market Cap
—
52W High
$0.09
52W Low
$0.09
ADV30
0
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 14,427,000 | 14,412,000 | -7,829,000 | -7,707,000 | 293,650,000 | 29,046,000 | 31,004,000 |
| Dec 2025 | 8,376,000 | 8,367,000 | -15,766,000 | -14,179,000 | 300,914,000 | 25,524,000 | 33,887,000 |
| Sep 2025 | 2,239,000 | 2,210,000 | -18,140,000 | -16,525,000 | 309,690,000 | 28,537,000 | 32,246,000 |
| Jun 2025 | 3,897,000 | 3,635,000 | -19,219,000 | -15,875,000 | 295,674,000 | 18,281,000 | 33,610,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-36,455,000
Investing CF
$6,467,000
Financing CF
$27,914,000
CapEx
$-565,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-166,179,000
Inventory
$443,000
Receivables
$7,390,000
ST Investments
$28,501,000
EBIT TTM
$-71,969,000
Pretax Income TTM
$-66,294,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$28,939,000
EBITDA
$-33,435,000
Free Cash Flow
$-2,571,625
Enterprise Value
—
Total Cash
$49,072,000
Total Debt
$19,670,000
Shares Out
—
Trailing EPS
—
Book Value
$1.81
ROE
-20.2%
ROA
-11.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 18,666,000 | -68,969,000 | -64,779,000 | 300,914,000 | 33,887,000 | — | -36,455,000 |
| Dec 2024 | 26,391,000 | -74,502,000 | -62,033,000 | 325,558,000 | 37,940,000 | — | -39,664,000 |
| Dec 2023 | 34,164,000 | -69,419,000 | -50,619,000 | 375,225,000 | 60,640,000 | — | 2,347,000 |
| Dec 2022 | 59,077,000 | -26,648,000 | -22,334,000 | 421,212,000 | 79,839,000 | — | -3,587,000 |
TTM Snapshot
Revenues TTM
$20,001,000
NetIncome TTM
$-41,965,000
OpCashFlow TTM
$0
Assets (Latest)
$325,558,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $44.10B | $559.07 | — |
| IQV | IQVIA HOLDINGS INC. | $38.68B | $235.02 | — |
| INCY | INCYTE CORP | $24.23B | $119.52 | — |
| MEDP | Medpace Holdings, Inc. | $16.11B | $577.11 | — |
| ICLR | ICON PLC | $12.62B | $163.57 | — |
News headlines (Yahoo Finance, 1h cache)
VERAXA Biotech (VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration
2026-07-27 19:37 · Yahoo
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
2026-07-27 11:00 · Yahoo
OmniAb Names Amechi Nwachuku Chief Operating Officer
2026-07-13 12:00 · Yahoo
OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher?
2026-07-03 13:13 · Yahoo
Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth
2026-06-02 10:20 · Yahoo
OmniAb (OABI) Q1 2026 Earnings Transcript
2026-05-08 14:10 · Yahoo
OmniAb, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
OmniAb Q1 Earnings Call Highlights
2026-05-08 11:07 · Yahoo
OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates
2026-05-08 02:25 · Yahoo
Bullish OmniAb Insiders Loaded Up On US$1.28m Of Stock
2026-04-22 11:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.